Testing & Diagnosis

COPD | Testing and Diagnosis

Testing & Diagnosis

Diagnosis for COPD can be achieved through simple breathing tests, such as spirometry, alongside other testing. Get Screened Today!

Diagnosis for COPD can be achieved through simple breathing tests, such as spirometry, alongside other testing. Get Screened Today!

According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Management Guidelines (2001), the definition of COPD is that:

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases.

In 2004, the American Thoracic Society (ATS) and European Respiratory Society (ERS) developed a document to standardize diagnosis and treatment of COPD. The definition of COPD in this document is similar to that developed in the GOLD guidelines:

COPD is a preventable and treatable disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking. Although COPD affects the lungs, it also produces significant systemic consequences.

Both definitions demonstrate the possibility of preventing and treating the disease with the help of early diagnosis. Diagnosis for COPD can be achieved through simple breathing tests, such as spirometry, alongside other testing.

Spirometry

The quickest and easiest method to diagnose COPD is with spirometry. According to the ATS/ERS guidelines, spirometry should be obtained from all individuals who have COPD symptoms, have/had a history of smoking and/or environmental exposure to smoke or occupational pollutants, and have a family history of chronic lung disease. (ATS/ERS 2004)

Bronchodilator Reversibility

The ATS/ERS guidelines recommend using bronchodilator reversibility at least once on a patient in order to “exclude asthma and to establish the best lung function for the individual patient, and, to a lesser degree, to estimate the prognosis” (ATS/ERS 2004).

Chest Radiography

Though it is not essential for diagnosis, chest radiography does help eliminate the possibility of other diseases such as pneumonia, cancer, and congestive heart failure (ATS/ERS 2004).

Alpha-1 Antitrypsin Deficiency Testing

The World Health Organization, ATS, ERS, and the Alpha-1 Foundation’s Medical and Scientific Advisory Committee recommend that individuals diagnosed with COPD should be tested for Alpha-1 Antitrypsin Deficiency (AAT). Because AATD is the most common known genetic risk factor for COPD at this time, it is important to test all individuals with COPD for this protein deficiency. Detection of this disease could lead to a different therapy for an individual with COPD.

Computed Tomography

If diagnosis for COPD is unclear, CT scanning is recommended.


Join Us on COPD360social

Sign In to Participate
Or register to become a member
1 in 40 Hospitalized